Trial · NCT04115059
Results by group11
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 11 of 11
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With at Least One Treatment-Emergent Adverse Event | Dasatinib | 3 | Participants | ||
| Overall Response Rate | Dasatinib | 0 | Participants | ||
| Complete Response Rate | Dasatinib | 0 | Participants | ||
| Very Good Partial Response Rate | Dasatinib | 0 | Participants | ||
| Partial Response Rate | Dasatinib | 0 | Participants | ||
| Minimal Response Rate | Dasatinib | 0 | Participants | ||
| Stable Disease Rate | Dasatinib | 3 | Participants | ||
| Progressive Disease Rate | Dasatinib | 2 | Participants | ||
| Progression Free Survival | Dasatinib | 5 | Full Range 0 to 5 | months | |
| Time to Next Therapy (TTNT) | Dasatinib | 6 | Full Range 1 to 6 | months | |
| Overall Survival | Dasatinib | 2 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04115059/results